Vivacell Biotechnology España
VivaCell Biotechnology España SLU, a wholly owned subsidiary of Emerald Health Sciences (Canada/USA), is a clinical stage Pharma Biotech company located in Córdoba, Spain. The company is dedicated to discovering and developing proprietary synthetic or semi-synthetic drug candidates that address significant unmet medical needs for the treatment of serious life-threatening conditions and other pathologies. The company’s primary goal is to significantly improve the treatment of neurovascular, peripheral vascular diseases and neurodegenerative diseases.
VivaCell Biotechnology España was founded in 2003, as a spin-off of the AINP (FP-V) and Cannabis (FP-VI) EU projects by Prof. Eduardo Muñoz together with a group of internationally renowned researchers in biomedicine, pharmacology and chemistry of natural products.